Skip to content
zameds

Atropine (Adco-atropine Sulphate, Atropine Eye)

Atropine

Adcock ingram limited

S3Read from the PI-PIL document and verified

Registration

Applicant
Adcock ingram limited
Registrations
4
Schedule source
SAHPRA documentation

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Adco-atropine sulphate injection 0,8 MG

1 ML ATROPINE SULPHATE A 0,8 MG

0,8 MGInjectionC0603CancelledNot determinedNone
Adco-atropine sulphate injection 0,6 MG

1 ML ATROPINE SULPHATE A 0,6 MG

0,6 MGInjectionC0607CancelledNot determinedNone
Adco-atropine sulphate injection 1,2 MG

1 ML ATROPINE SULPHATE A 1,2 MG

1,2 MGInjectionC0608CancelledNot determinedNone
Atropine eye drops

EACH 1 ml CONTAINS :ATROPINE SULPHATE 10 mg

10 mg/mlSterile eye dropsJ0312J/15.4/312Approved 28 October 2022RegisteredS3PIPIL

Regulatory status

Where S3 sits on the scale

Needs a doctor's prescription, dispensed by a pharmacist.

Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S3, read from the product's PI-PIL leaflet.

The Consolidated Schedules list this ingredient up to S4; the leaflet's S3 applies to this product.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Atropine sulphate

  • S4: Atropine

    • when intended for use in injections. (S2)
    • except when intended for use in ophthalmic preparations. (S3)

    Consolidated Schedules 06 July 2026, lines 5387 to 5391

  • S3: Atropine

    • when intended for use in ophthalmic preparations; (S2)
    • except when intended for use in injections. (S4)

    Consolidated Schedules 06 July 2026, lines 3150 to 3154

  • S2: Atropine

    • when intended for use in ophthalmic preparations; (S3)
    • when intended for use in injections. (S4)

    Consolidated Schedules 06 July 2026, lines 1631 to 1635

Pharmacological class: Others. (class 15.4)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C17H23NO3289.40 g/mol

[(1S,5R)-8-Methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate

Drag to rotate. Structure from PubChem CID 174174.

SAHPRA documents

Schedule verified from official documents

Schedule Verification

This medication's schedule (S3) has been verified from official SAHPRA documents with 90% confidence.

These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles